25 290

Cited 5 times in

Widely varying TNF-alpha levels in patients with myasthenia gravis.

Authors
Lee, JS; Joo, IS; Seok, JI
Citation
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 30(3):259-262, 2009
Journal Title
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN
1590-18741590-3478
Abstract
Animal studies have indicated an important role of tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of myasthenia gravis (MG), and trials of monoclonal antibodies that block TNF-alpha have shown clinical improvement. However, before a TNF-alpha blocking agent is proposed for treatment of MG, whether serum TNF-alpha level correlates with the patient's condition should be confirmed. Therefore, we evaluated the relationship between the serum TNF-alpha level and clinical factors, including the quantitative MG score and the anti-acetylcholine receptor antibody level, in 33 MG patients. TNF-alpha levels ranged from 0.44 to 3.63 pg/mL and did not correlate with clinical factors. Overall, we found that serum TNF-alpha levels varied greatly among MG patients.
MeSH terms
AdultAgedAutoantibodies/blood*Autoantibodies/immunologyCase-Control StudiesFemaleHumansImmunosuppressive Agents/therapeutic useMaleMiddle AgedMyasthenia Gravis/blood*Myasthenia Gravis/drug therapyMyasthenia Gravis/immunologyReceptors, Nicotinic/immunology*Reference ValuesSeverity of Illness IndexTumor Necrosis Factor-alpha/blood*
DOI
10.1007/s10072-009-0023-0
PMID
19214380
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Neurology
AJOU Authors
이진수주인수
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse